- Home
- WASH vs KURA Comparison
WASH vs KURA Comparison
Compare WASH & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- KURA
- Stock Information
- Founded
- WASH 1800
- KURA 2014
- Country
- WASH United States
- KURA United States
- Employees
- WASH N/A
- KURA N/A
- Industry
- WASH Major Banks
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WASH Finance
- KURA Health Care
- Exchange
- WASH Nasdaq
- KURA Nasdaq
- Market Cap
- WASH 647.4M
- KURA 492.9M
- IPO Year
- WASH N/A
- KURA N/A
- Fundamental
- Price
- WASH $28.38
- KURA $5.76
- Analyst Decision
- WASH Buy
- KURA Strong Buy
- Analyst Count
- WASH 3
- KURA 11
- Target Price
- WASH $33.67
- KURA $23.89
- AVG Volume (30 Days)
- WASH 162.5K
- KURA 1.5M
- Earning Date
- WASH 04-21-2025
- KURA 05-01-2025
- Dividend Yield
- WASH 7.89%
- KURA N/A
- EPS Growth
- WASH N/A
- KURA N/A
- EPS
- WASH N/A
- KURA N/A
- Revenue
- WASH $110,088,000.00
- KURA $67,991,000.00
- Revenue This Year
- WASH $59.25
- KURA $44.32
- Revenue Next Year
- WASH $9.15
- KURA $173.73
- P/E Ratio
- WASH N/A
- KURA N/A
- Revenue Growth
- WASH N/A
- KURA N/A
- 52 Week Low
- WASH $24.70
- KURA $5.41
- 52 Week High
- WASH $40.59
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- WASH 51.42
- KURA 39.73
- Support Level
- WASH $27.68
- KURA $5.48
- Resistance Level
- WASH $28.74
- KURA $6.76
- Average True Range (ATR)
- WASH 0.66
- KURA 0.34
- MACD
- WASH 0.22
- KURA -0.02
- Stochastic Oscillator
- WASH 85.83
- KURA 21.88
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.